2021 All Stakeholder Briefing - Follow Up
On Wednesday 13th October, we hosted our Annual All Stakeholder Briefing, focusing on Early diagnosis for rare and less common cancers:...
top of page
Cancer52 - 2021 All Stakeholder Briefing
Cancer52's All Stakeholder Briefing will take place (virtually) on Wednesday 13th October 2021 from 09:30am until 12:30pm. The focus for...
Launch of Do You C Us? campaign
We are pleased to have partnered with Pfizer to launch the Do You C Us? Campaign. The Do You C Us? Campaign aims to raise awareness of...
Review of Psychosocial Support undertaken by Cancer52 members during covid-19
A review of the work of 13 Cancer52 charities undertaken to provide psychosocial support to people with rare and less common cancers...
The NICE Response
The final response, including the full list of charities who signed up, has now been submitted. If you would like to see a copy of this...
Cancer52 publishes England results of its second patient survey
With help from its member charities, Cancer52 ran a second survey of people with rare and less common cancers from early December 2020 to...
Annual Review 2019/20
Cancer52 is delighted to present its Annual Review 2019 / 20. This report not only shows the standing of the organisation prior to the...
NICE Methods Review
In December 2020, Cancer52 submitted a consultation response from Cancer52 to the NICE Methods Review. The response was supported by 23...
Health and Social Care Select Committee Report
The Health and Social Care Select Committee have published their report on the inquiry 'Delivering core NHS and care services during the...
Cancer52 works with members to raise funds
Cancer52 is proud to have joined forces with 19 other rare and less common cancer charities in a major new fundraising campaign that has...
bottom of page